BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25211360)

  • 1. Treating tuberculosis in solid organ transplant recipients.
    Sun HY
    Curr Opin Infect Dis; 2014 Dec; 27(6):501-5. PubMed ID: 25211360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis-associated immune reconstitution syndrome in solid-organ transplant recipients.
    Sun HY; Munoz P; Torre-Cisneros J; Aguado JM; Lattes R; Montejo M; Garcia-Reyne A; Bouza E; Valerio M; Lara R; John GT; Bruno D; Singh N
    Transplantation; 2013 May; 95(9):1173-81. PubMed ID: 23435454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period.
    Sidhu A; Verma G; Humar A; Kumar D
    Transplantation; 2014 Sep; 98(6):671-5. PubMed ID: 24825525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
    Ha YE; Joo EJ; Park SY; Wi YM; Kang CI; Chung DR; Joh JW; Lee SK; Song JH; Peck KR
    Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifabutin for treating tuberculosis in solid organ transplant recipients: A retrospective observational study and literature review.
    Gomila-Grange A; Pérez-Recio S; Camprubí-Ferrer D; Lladó L; Fava A; García-Romero E; Grijota-Camino MD; Sabé N; Santin M
    Transpl Infect Dis; 2021 Apr; 23(2):e13471. PubMed ID: 32959494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis.
    Holty JE; Sista RR
    Curr Opin Organ Transplant; 2009 Dec; 14(6):613-8. PubMed ID: 19741533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
    Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P
    Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of tuberculosis in solid organ transplant recipients.
    Abad CL; Razonable RR
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):63-73. PubMed ID: 31826668
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.
    Abad CLR; Deziel PJ; Razonable RR
    Transpl Infect Dis; 2019 Dec; 21(6):e13178. PubMed ID: 31541575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial infections in solid organ transplant recipients.
    Meije Y; Piersimoni C; Torre-Cisneros J; Dilektasli AG; Aguado JM;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():89-101. PubMed ID: 24707957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis infection in liver transplantation.
    Yehia BR; Blumberg EA
    Liver Transpl; 2010 Oct; 16(10):1129-35. PubMed ID: 20879011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in Taiwan.
    Chen CH; Shu KH; Ho HC; Cheng SB; Lin CC; Wei HJ; Lin CH; Chang SN; Wu MJ
    Transplant Proc; 2014 May; 46(4):1032-5. PubMed ID: 24815120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.
    García-Goez JF; Munera GA; Rojas V; Pacheco R; Caylá JA; Miro JM
    Int J Tuberc Lung Dis; 2017 Nov; 21(11):1155-1159. PubMed ID: 29037296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era.
    Sun HY; Munoz P; Torre-Cisneros J; Aguado JM; Lattes R; Montejo M; Garcia-Reyne A; Bouza E; Valerio M; Lara R; Wagener MM; John GT; Bruno D; Singh N
    Prog Transplant; 2014 Mar; 24(1):37-43. PubMed ID: 24598564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome.
    el-Agroudy AE; Refaie AF; Moussa OM; Ghoneim MA
    J Nephrol; 2003; 16(3):404-11. PubMed ID: 12832742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolones for the treatment of latent
    Silva JT; San-Juan R; Fernández-Ruiz M; Aguado JM
    World J Gastroenterol; 2019 Jul; 25(26):3291-3298. PubMed ID: 31341356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients.
    Natori Y; Ferreira VH; Nellimarla S; Husain S; Rotstein C; Humar A; Kumar D
    Transplantation; 2019 Jan; 103(1):210-215. PubMed ID: 29944616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatotoxicity in solid organ transplants recipients being treated for tuberculosis.
    Schultz V; Marroni CA; Amorim CS; Baethgen LF; Pasqualotto AC
    Transplant Proc; 2014 Dec; 46(10):3606-10. PubMed ID: 25498098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges.
    Subramanian AK
    Curr Opin Infect Dis; 2014 Aug; 27(4):316-21. PubMed ID: 24977684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.